Mode
Text Size
Log in / Sign up

HPV prevalence in breast cancer tissue is 23% with higher risk in specific subtypesAnalysis shows link between HPV and breast cancer tissue

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that HPV is present in 23% of breast cancer samples, with higher prevalence observed in luminal B subtypes.

This meta-analysis synthesized data from 82 studies involving 7,683 breast cancer tissue samples and healthy controls to evaluate the prevalence and association of Human Papillomavirus (HPV) in breast cancer. The analysis found an overall prevalence of HPV in breast cancer specimens of 23% (95%CI: 19%-28%).

Specific findings highlighted a higher likelihood of HPV detection in breast cancer compared to healthy controls across multiple study designs, including case-control (OR 6.34) and cross-sectional designs (OR 2.83). Regional variations were noted, with Oceania showing a 38% prevalence and South America showing the most pronounced association (OR 11.66). Additionally, HPV prevalence was higher in low-income settings (34%) and specifically within the luminal B subtype (44%).

The authors note that while these findings suggest a possible link between HPV and breast cancer development, further well-designed studies are required to confirm its specific role in tumorigenesis. Clinical application is currently limited by the need for more definitive evidence regarding causality.

How this fits prior evidence

This meta-analysis addresses a gap in understanding the environmental and viral factors associated with breast cancer. While prior coverage has focused on biomarkers like ctDNA for prognosis and various supportive interventions such as nursing protocols or AI imaging, this study provides data on the prevalence of HPV in breast cancer tissue. It identifies an increased likelihood of HPV detection (OR 5.06) compared to healthy controls, though it does not confirm a causal role in tumorigenesis.

When we think of the human papillomavirus (HPV), we often focus on its link to cervical health. However, new data suggests it may also play a role in breast cancer. By looking at over 7,600 tissue samples across dozens of studies, researchers found that HPV was present in about 23% of breast cancer cases.

The study highlights specific patterns in where and how often the virus appears. For example, the highest rates were seen in Oceania and in low-income settings. The data also showed a much higher likelihood of finding the virus in cancerous tissue compared to healthy tissue. Specifically, patients with the luminal B subtype of breast cancer showed a 44% rate of HPV presence.

While these numbers show a strong connection, it is important to be careful about what this means for treatment today. The researchers noted that while there is a clear link between the virus and the cancer, more well-designed studies are needed to confirm exactly how the virus helps cause tumors. For now, the findings suggest a possible link that warrants closer look.

What this means for you:
Research shows HPV is significantly more likely to be found in breast cancer tissue than in healthy tissue.

Common questions

Is there a link between HPV and breast cancer?

Yes, the study found that HPV was present in 23% of breast cancer samples. There was an increased likelihood of finding the virus in cancerous tissue compared to healthy controls. However, researchers note that more studies are needed to confirm exactly how the virus causes tumors.

Which types of breast cancer are most linked to HPV?

The data showed a 44% rate of HPV presence in the luminal B subtype of breast cancer. This was the highest rate recorded among the different subtypes studied.

Does location or economic status affect how often HPV is found in breast cancer?

Yes, the study found a 38% prevalence in Oceania and a 34% prevalence in low-income settings. These were among the highest rates reported in the analysis.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
INTRODUCTION: Breast cancer (BC) is the most common cancer among women worldwide, with over 2.3 million new cases annually. Recent studies suggest that Human Papillomavirus (HPV), a known oncogenic virus, may be involved in BC development. This study investigates HPV prevalence in BC samples and its potential role in tumorigenesis. METHODS: Random-effects meta-analyses were conducted to estimate raw proportions and odds ratio (OR), with 95% confidence intervals (CIs). Heterogeneity was assessed using I. Statistical significance was set at p < 0.05. Analyses were performed in R 4.5.0 RESULTS: Our meta-analysis encompassed 82 studies and evaluated 7,683 breast cancer (BC) tissue samples to assess the presence of HPV. The overall prevalence of HPV in BC specimens was estimated at 23% (95%CI: 19%-28%). When stratified by continent, Oceania exhibited the highest regional prevalence at 38%. Comparative analysis between BC tissues and healthy controls revealed a significantly increased likelihood of HPV detection in the cancer group (OR 5.06; P < 0.001). This association remained statistically robust in both case-control (OR 6.34; P < 0.001) and cross-sectional designs (OR 2.83; P < 0.001). Among continents, South America demonstrated the most pronounced association (OR 11.66; P = 0.005). Subgroup analysis based on economic classification indicated that countries with low-income settings had the highest HPV prevalence (34%; 95%CI: 9%-73%). Evaluation by BC subtype revealed that luminal B had the highest HPV-positive rate (44%; 95%CI: 27%-61%). CONCLUSION: This meta-analysis reveals a global presence of HPV in BC and suggests a possible link. Further well-designed studies are needed to confirm its role in tumorigenesis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.